Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 20

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook...

Related Keywords

China , India , Russia , Brazil , Abbott Binax , Robertb Ford , , International Pediatric Nutrition , Linkedin , Us Centers For Medicare Medicaid Services , Facebook , Abbott Laboratories , European Union Medical Device , Core Laboratory , Medicaid Services , Virtual Clinic , Adult Nutrition , Pediatric Nutrition , Molecular Diagnostics , Rapid Diagnostics , Emerging Markets , Medical Devices , Heart Failure , Structural Heart , Diabetes Care , Neurosphere Virtual Clinic , Amplatzer Amulet Left Atrial Appendage Occluder , Aristocrats Index , Investor Relations , Private Securities Litigation Reform Act , Caution Concerning Forward Looking , Annual Report , Consolidated Statement , Quarter Ended December , Operating Cost , Continuing Operations , Discontinued Operations , Common Share , Specified Items , Common Shares , Dilutive Common Stock Options , Financial Information From Continuing , Diluted Earnings , Ended December , Cost Reduction Initiatives , Financial Information From Continuing Operations , Gross Margin , European Union , Medical Device , Vitro Diagnostics Medical Device , Abbott ,